These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10806853)

  • 1. Variations and clinical significance of coagulation and fibrinolysis parameters in patients with diabetes mellitus.
    Hu J; Wei W; Din G; Yuan L; Liu Z
    J Tongji Med Univ; 1998; 18(4):233-5. PubMed ID: 10806853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications.
    Erem C; Hacihasanoğlu A; Celik S; Ovali E; Ersöz HO; Ukinç K; Deger O; Telatar M
    Med Princ Pract; 2005; 14(1):22-30. PubMed ID: 15608477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.
    Carmassi F; Morale M; Puccetti R; De Negri F; Monzani F; Navalesi R; Mariani G
    Thromb Res; 1992 Sep; 67(6):643-54. PubMed ID: 1440530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1.
    Aso Y; Matsumoto S; Fujiwara Y; Tayama K; Inukai T; Takemura Y
    Metabolism; 2002 Apr; 51(4):471-6. PubMed ID: 11912556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercoagulability and high lipoprotein(a) levels in patients with type II diabetes mellitus.
    Morishita E; Asakura H; Jokaji H; Saito M; Uotani C; Kumabashiri I; Yamazaki M; Aoshima K; Hashimoto T; Matsuda T
    Atherosclerosis; 1996 Feb; 120(1-2):7-14. PubMed ID: 8645373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis.
    Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A
    Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome.
    Ames PR; Lupoli S; Alves J; Atsumi T; Edwards C; Iannaccone L; Khamashta MA; Hughes GR; Brancaccio V
    Br J Rheumatol; 1997 Oct; 36(10):1045-50. PubMed ID: 9374919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The haemocoagulation system and macroangiopathy in insulin dependent (type I) diabetes.
    Fuller JH
    Ann Clin Res; 1984; 16(3):137-41. PubMed ID: 6236737
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in the blood coagulation, fibrinolysis, and cytokine profile during laparoscopic and open cholecystectomy.
    Schietroma M; Carlei F; Mownah A; Franchi L; Mazzotta C; Sozio A; Amicucci G
    Surg Endosc; 2004 Jul; 18(7):1090-6. PubMed ID: 15136925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of D-dimer with microalbuminuria in patients with type 2 diabetes mellitus.
    Wakabayashi I; Masuda H
    J Thromb Thrombolysis; 2009 Jan; 27(1):29-35. PubMed ID: 17929144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
    Christe M; Fritschi J; Lämmle B; Tran TH; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):138-43. PubMed ID: 6084321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low order correlations of lipoprotein(a) with other blood lipids and with coagulation and fibrinolysis parameters in hypertensive and diabetic patients.
    Donders SH; Lustermans FA; van Wersch JW
    Blood Coagul Fibrinolysis; 1992 Jun; 3(3):249-56. PubMed ID: 1386533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disorders of hemostasis during the surgical management of severe necrotizing pancreatitis.
    Radenković D; Bajec D; Karamarkovic A; Stefanovic B; Milic N; Ignjatović S; Gregoric P; Milicevic M
    Pancreas; 2004 Aug; 29(2):152-6. PubMed ID: 15257107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of hypercoagulability over hyperglycemia for vascular complication in type 2 diabetes.
    Yamada T; Sato A; Nishimori T; Mitsuhashi T; Terao A; Sagai H; Komatsu M; Aizawa T; Hashizume K
    Diabetes Res Clin Pract; 2000 Jul; 49(1):23-31. PubMed ID: 10808060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of coagulation in diabetes mellitus in relation to the presence of vascular complications.
    Ford I; Singh TP; Kitchen S; Makris M; Ward JD; Preston FE
    Diabet Med; 1991 May; 8(4):322-9. PubMed ID: 1830255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of 17 beta-oestradiol on variables of coagulation and fibrinolysis in postmenopausal women with type 2 diabetes mellitus.
    Brussaard HE; Leuven JA; Krans HM; Kluft C
    Vascul Pharmacol; 2002 Aug; 39(3):141-7. PubMed ID: 12616982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy.
    van der Pas R; de Bruin C; Leebeek FW; de Maat MP; Rijken DC; Pereira AM; Romijn JA; Netea-Maier RT; Hermus AR; Zelissen PM; de Jong FH; van der Lely AJ; de Herder WW; Lamberts SW; Hofland LJ; Feelders RA
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1303-10. PubMed ID: 22278425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coagulation and fibrinolytic parameters in patients with various angiopathies--analysis in cerebral thrombosis, diabetic and vasculitic neuropathies].
    Kohriyama T; Katayama S; Tanaka E; Yamamura Y; Nakamura S
    Rinsho Shinkeigaku; 1993 Jun; 33(6):606-11. PubMed ID: 8403679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-grade risk of hypercoagulable state in patients suffering from diabetes mellitus type 2.
    Ruszkowska-Ciastek B; Sokup A; Wernik T; Rhone P; Góralczyk K; Bielawski K; Fijałkowska A; Nowakowska A; Rhone E; Rość D
    J Zhejiang Univ Sci B; 2015 Sep; 16(9):788-95. PubMed ID: 26365121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.